Previous studies have observed the effects of NT-proBNP on all-cause mortality, short and long-term all-cause mortality, cardiac death, functional outcomes, and short and long-term functional outcomes of ischemic stroke patients [23]. This evidence concerns the gene NPPB and ischemic stroke.